Wang Y, Zhang Z, Kastens E, Lubet RA, You M. (2003). Mice with alterations in both p53 and Ink4a/Arf display a striking increase in lung tumor multiplicity and progression: differential chemopreventive effect of budesonide in wild-type and mutant A/J mice. Cancer Res. 63(15):4389–95.

Zhang Q, Pan J, Lubet RA, Komas SM, Kalyanaraman B, Wang Y, You M. (2015). Enhanced antitumor activity of 3-bromopyruvate in combination with rapamycin in vivo and in vitro. Cancer Prev Res (Phila). 8(4):318–26.

Pan J, Zhang Q, Liu Q, Komas SM, Kalyanaraman B, Lubet RA, Wang Y, You M. (2014). Honokiolinhibits lung tumorigenesis through inhibition of mitochondrial function. Cancer Prev Res (Phila). 7(11):1149–59.

Pan J, Lee Y, Zhang Q, Xiong D, Wan TC, Wang Y, You M. (2017). Honokiol decreases lung cancer metastasis

Liu P, Wang Y, Vikis H, Maciag A, Wang D, Lu Y, Liu Y, You M. (2006). Candidate lung tumor susceptibility genes identified through whole-genome association analyses in inbred mice. Nat Genet. 38(8):888–95.

Lu Y, Lemon W, Liu PY, Yi Y, Morrison C, Yang P, Sun Z, Szoke J, Gerald WL, Watson M, Govindan R, You M. (2006). A gene expression signature predicts survival of patients with stage I non-small cell lung cancer. PLoS Med. 3(12):e467. PMCID: PMC1716187

Govindan R, Ding L, Griffith M, Subramanian J, Dees ND, Kanchi KL, Maher CA, Fulton R, Fulton L, Wallis J, Chen K, Walker J, McDonald S, Bose R, Ornitz D, Xiong D, You M, Dooling DJ, Watson M, Mardis ER, Wilson RK. (2012). Genomic landscape of non-small cell lung cancer in smokers and never-smokers . Cell. 150(6):1121–34. PMCID: PMC3656590

Xiong D, Wang Y, Kupert E, Simpson C, Pinney SM, Gaba CR, Mandal D, Schwartz AG, Yang P, de Andrade M, Pikielny C, Byun J, Li Y, Stambolian D, Spitz MR, Liu Y, Amos CI, Bailey-Wilson JE, Anderson M, You M. (2015). A recurrent mutation in PARK2 is associated with familial lung cancer. Am J Hum Genet. 96(2):301–8 . PMCID: PMC4320264

View All Publications